The US Bankruptcy Court gave an order approving the sale of the substantially all the assets of Codiak BioSciences, Inc. on June 6, 2023. The debtor has been authorized to sell substantially all the assets to Lonza Houston, Inc. for a purchase price of $3.4 million in cash pursuant to the asset purchase agreement. Under the terms of the asset purchase agreement, the buyer shall make an earnest money deposit of $0.34 million upon the execution of the agreement.

The buyer is represented by Jenner & Block LLP as its legal counsel.